PNEUMOCOCCAL VACCINES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Table of Contents (Version-2026)

1.  Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
• Market Definition and Scope
• Executive Summary
• Global Pneumococcal Vaccines Market, By Vaccine Type
• Global Pneumococcal Vaccines Market, By Target Population
• Global Pneumococcal Vaccines Market, By Route of Administration
• Global Pneumococcal Vaccines Market, By Distribution Channel
• Global Pneumococcal Vaccines Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER’s Analysis
• Merger and Acquisition Scenario

4. Global Pneumococcal Vaccines Market, By Vaccine Type, 2021 - 2033, (USD Bn)

• Introduction
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2022 - 2033
• Segment Trends
• Pneumococcal Conjugate Vaccines (PCVs)
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• PCV13 (Prevnar 13/Prevenar 13)
• PCV10 (Synflorix)
• PCV7 (Prevnar/Prevenar)
• Pneumococcal Polysaccharide Vaccines (PPVs)
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• PPSV23 (Pneumovax 23)
• PPSV14 (Pneumo 14)

5. Global Pneumococcal Vaccines Market, By Target Population, 2021 - 2033, (USD Bn)

• Introduction
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2022 - 2033
• Segment Trends
• Adults (≥ 65 years)
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Children (< 5 years)
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• High-Risk Adults (18-64 years)
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Pneumococcal Vaccines Market, By Route of Administration, 2021 - 2033, (USD Bn)

• Intramuscular
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Subcutaneous
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Pneumococcal Vaccines Market, By Distribution Channel, 2021 - 2033, (USD Bn)

• Introduction
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2022 - 2033
• Segment Trends
• Hospital Pharmacies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Retail Pharmacies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Online Pharmacies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Pneumococcal Vaccines Market, By Region, 2021 - 2033, (USD Bn)

• Introduction
• Market Share (%) Analysis, 2026,2028 & 2033, (USD Bn)
• Market Y-o-Y Growth Analysis (%), 2022- 2033, (USD Bn)
• Regional Trends
• North America
• Introduction
• Market Size and Forecast, By Vaccine Type, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Target Population, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
• U.S.
• Canada
• Latin America
• Introduction
• Market Size and Forecast, By Vaccine Type, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Target Population, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Europe
• Introduction
• Market Size and Forecast, By Vaccine Type, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Target Population, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
• Introduction
• Market Size and Forecast, By Vaccine Type, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Target Population, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• Introduction
• Market Size and Forecast, By Vaccine Type, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Target Population, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
• Introduction
• Market Size and Forecast, By Vaccine Type, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Target Population, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
• Market Size and Forecast, By Country/Sub-region, 2021 - 2033, (USD Bn)
• South Africa
• North Africa
• Central Africa

9. Competitive Landscape

• Pfizer Inc.
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Merck & Co., Inc.
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• GlaxoSmithKline plc (GSK)
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Sanofi
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• CSL Limited
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Serum Institute of India Pvt. Ltd.
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Vaxcyte, Inc.
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Astellas Pharma Inc.
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Panacea Biotec Ltd.
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Walvax Biotechnology Co., Ltd.
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Beijing Minhai Biotechnology Co., Ltd.
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Merck KGaA
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Takeda Pharmaceutical Company Limited
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• AbbVie Inc.
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Novartis AG
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Johnson & Johnson
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Biovac
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Bharat Biotech
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Inovio Pharmaceuticals, Inc.
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Hilleman Laboratories Pvt. Ltd.
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us